Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · Real-Time Price · USD
0.9702
-0.0498 (-4.88%)
At close: Aug 13, 2025, 4:00 PM
0.9734
-0.0092 (-0.94%)
Pre-market: Aug 14, 2025, 8:47 AM EDT
Akari Therapeutics, Market Cap
Akari Therapeutics, has a market cap or net worth of $31.64 million as of August 14, 2025. Its market cap has decreased by -37.33% in one year.
Market Cap
31.64M
Enterprise Value
31.31M
1-Year Change
-37.33%
Ranking
Category
Stock Price
$0.97
Market Cap Chart
Since September 28, 2015, Akari Therapeutics,'s market cap has decreased from $291.48M to $31.64M, a decrease of -89.14%. That is a compound annual growth rate of -20.12%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 592.95B |
Johnson & Johnson | 420.06B |
AbbVie | 355.91B |
UnitedHealth Group | 246.17B |
AstraZeneca | 240.81B |
Novartis AG | 234.72B |
Novo Nordisk | 227.37B |
Abbott Laboratories | 225.22B |